Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Leases: 2024-2025

Historic Current Leases for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $1.4 million.

  • Kura Oncology's Current Leases fell 15.49% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 15.49%. This contributed to the annual value of $1.9 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Kura Oncology's Current Leases stood at $1.4 million, which was down 15.74% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Current Leases peaked at $1.9 million during Q1 2025, and registered a low of $1.4 million during Q1 2024.
  • For the 2-year period, Kura Oncology's Current Leases averaged around $1.6 million, with its median value being $1.7 million (2024).
  • Examining YoY changes over the last 5 years, Kura Oncology's Current Leases showed a top increase of 39.77% in 2025 and a maximum decrease of 15.49% in 2025.
  • Quarterly analysis of 2 years shows Kura Oncology's Current Leases stood at $1.9 million in 2024, then fell by 15.49% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.7 million for Q2 2025, and $1.9 million during Q1 2025.